Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer

被引:26
|
作者
Haroun, Iman
Graham, Tracy
Poll, Aletta
Sun, Ping
Hill, Kimberley [1 ]
Weitzner, Eleanor [2 ]
Narod, Steven [3 ]
Warner, Ellen [3 ]
机构
[1] Sunnybrook Odette Canc Ctr, Dept Med, Div Med Oncol, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON M5S 1A1, Canada
来源
BREAST | 2011年 / 20卷 / 03期
关键词
BRCA1; MRI; Mastectomy; BRCA2; Surveillance; BILATERAL PROPHYLACTIC MASTECTOMY; BRCA2 MUTATION CARRIERS; TAMOXIFEN; IMPACT;
D O I
10.1016/j.breast.2011.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To determine the reasons that motivate women in a cohort of women under intensive surveillance for breast cancer to undergo risk-reducing mastectomy (RRM). Patients and methods: Women with a BRCA1 or BRCA2 mutation who were enrolled in an MRI-based breast screening study were eligible to participate in this survey. A self-administered questionnaire was given to women who did, and who did not terminate annual MRI-based surveillance in order to undergo RRM. The questionnaire included information on family history, risk perception and satisfaction with screening. In addition, women were asked to provide the principal reason for their choice of having preventive surgery or not, and were asked about their satisfaction with this choice. Results: 246 women without breast cancer participated in the study. Of these, 39 women (16%) elected to have RRM at some point after initiating screening. Although women who had a mother or sister with breast cancer were more likely to opt for RRM than were women with no affected first-degree relative (21% versus 10%) this did not reach statistical significance. Women who perceived their breast cancer risk to be greater than 50% were more likely to opt for RRM than were women who estimated their risk to be less than 50% (19% versus 6%). Fear of cancer was the most common reason cited for choosing to have RRM (38% of respondents) followed by having had a previous cancer, (25%), then concern over their children (16%). Conclusion: Among women with a BRCA mutation who are enrolled in an MRI-based screening program, a high perception of personal breast cancer risk and a history of breast cancer in a first-degree relative are predictors of the decision to have RRM. (C) 2011 Published by Elsevier Ltd.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 50 条
  • [21] Screening breast MRI in high-risk women undergoing prophylactic mastectomy
    SE McWilliams
    Breast Cancer Research, 14
  • [22] Breast MRI for women with hereditary cancer risk
    Robson, ME
    Offit, K
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11): : 1368 - 1370
  • [23] Screening breast MRI in high-risk women undergoing prophylactic mastectomy
    McWilliams, S. E.
    BREAST CANCER RESEARCH, 2012, 14
  • [24] Contralateral Risk-Reducing Mastectomy in Young Breast Cancer Patients with and without Genetic Cancer Risk Assessment
    Phuong L. Mai
    Veronica I. Lagos
    Melanie R. Palomares
    Jeffrey N. Weitzel
    Annals of Surgical Oncology, 2008, 15 : 3415 - 3421
  • [25] Contralateral Risk-Reducing Mastectomy in Young Breast Cancer Patients with and without Genetic Cancer Risk Assessment
    Mai, Phuong L.
    Lagos, Veronica I.
    Palomares, Melanie R.
    Weitzel, Jeffrey N.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (12) : 3415 - 3421
  • [26] Hereditary breast cancer: screening and risk reducing surgery
    Renzulli, Matteo
    Zanotti, Simone
    Clemente, Alfredo
    Mineo, Giangaspare
    Tovoli, Francesco
    Reginelli, Alfonso
    Barile, Antonio
    Cappabianca, Salvatore
    Taffurelli, Mario
    Golfieri, Rita
    GLAND SURGERY, 2019, 8 : S142 - S149
  • [27] Risk-reducing surgery for women at high risk of epithelial ovarian cancer
    Gaughan, Eve Maria Geraldine
    Walsh, Thomas Anthony
    OBSTETRICIAN & GYNAECOLOGIST, 2014, 16 (03): : 185 - 191
  • [28] Unveiling Inequities: Racial Disparities in Risk-Reducing Mastectomy for Breast Cancer Prevention
    Knoedler, Samuel
    Diatta, Fortunay
    Klimitz, Felix J.
    Noel, Olivier
    Kempa, Joanna
    Obed, Doha
    Song, Seung-Yong
    Mayer, Horacio
    Kim, Bong-Sung
    Kauke-Navarro, Martin
    Pomahac, Bohdan
    Butler, Paris D.
    CLINICAL BREAST CANCER, 2025, 25 (03) : e312 - e320
  • [29] ASO Visual Abstract: Awareness and Candidacy for Endocrine Prevention and Risk-Reducing Mastectomy of Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment
    Alhassan, Basmah
    Rjeily, Marianne Bou
    Villareal-Corpuz, Victor
    Prakash, Ipshita
    Basik, Mark
    Boileau, Jean Francois
    Martel, Karyne
    Pollak, Michael
    Foulkes, William D.
    Wong, Stephanie M.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (02) : 1031 - 1032
  • [30] ASO Visual Abstract: Awareness and Candidacy for Endocrine Prevention and Risk-Reducing Mastectomy of Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment
    Basmah Alhassan
    Marianne Bou Rjeily
    Victor Villareal-Corpuz
    Ipshita Prakash
    Mark Basik
    Jean Francois Boileau
    Karyne Martel
    Michael Pollak
    William D. Foulkes
    Stephanie M. Wong
    Annals of Surgical Oncology, 2024, 31 : 1031 - 1032